Delivery Order SPE2DB22D2206-SPE2DB25FJA85
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,058.49 firm fixed-price delivery order is for the supply of 4,564,571,395 units of the drug Menopur, a medication used in fertility treatments. The contract has an ultimate completion date of May 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,743.32, is for the delivery of 4,562,704,677 units of Menopur 75 unit vials, a medical product used in the treatment of infertility. The contract has a period of performance running through November 6, 2023. This delivery order is issued under AmerisourceBergen's...
- This contract award to AmerisourceBergen Drug Corp is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific award for $24,817.68 is for the supply of 4,563,828,136 units of the pharmaceutical product Menopur, a medication used for fertility treatment. The contract has a period of performance through March 4, 2024 and is a firm fixed-price arrangement....
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $138,589.46 firm-fixed-price contract is for the delivery of 4,568,261,488 units of the drug Menopur, a fertility medication, with a period of performance through May 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $8,036.71 delivery order to AmerisourceBergen Drug Corp for Menopur 75 Unit Vials, with an ultimate completion date of July 24, 2025. This contract employs firm fixed pricing and was competitively awarded with no set-aside designation. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $90,984.84, is for the delivery of Menopur 75 unit vials, a fertility medication. The contract is a firm fixed-price, non-set-aside award with a performance period through April 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00,...
- The U.S. Defense Logistics Agency (DLA) has awarded a $8,272.56 Firm Fixed Price Delivery Order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,595,693 units of Menopur 75 Unit Vials. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities in support of military...
- This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,565,153,377 units of the drug Menopur, a 75-unit vial, at a ceiling value of $23,500.52. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November...
- This is a $26,176.07 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,394,947 units of MENOPUR 75 unit vials. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $18,613.26 firm fixed price delivery order is for the supply of Menopur 75 unit vials, a specialty pharmaceutical product. The award falls under a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp valued at up to $999,999,999.00, which serves as the primary vehicle...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJA85Delivery Order
The Defense Logistics Agency awarded a $24,529.17 delivery order to AmerisourceBergen Drug Corp for 75-unit vials of Menopur, a fertility medication used in assisted reproductive procedures. This is a firm fixed price, competitively awarded contract with an ultimate completion date of July 24, 2025, with performance to be completed in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. This prime vendor agreement serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply an extensive range of medications and medical supplies to military healthcare programs worldwide, including support for the Defense Health Agency and U.S. Coast Guard. The delivery order reflects the company's established role as a critical federal pharmaceutical distributor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $24.5k | 7/23/25 |